Kevy'S Generics Profile
Key Indicators
- Authorised Capital ₹ 1.11 Cr
as on 16-07-2024
- Paid Up Capital ₹ 1.10 Cr
as on 16-07-2024
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 26.99 Cr
as on 16-07-2024
- Satisfied Charges ₹ 3.15 Cr
as on 16-07-2024
- Revenue 31.33%
(FY 2023)
- Profit 6741.07%
(FY 2023)
- Ebitda 158.00%
(FY 2023)
- Net Worth 5.29%
(FY 2023)
- Total Assets 14.75%
(FY 2023)
About Kevy'S Generics
The Corporate was formerly known as G M S Pharmaceuticals Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.11 Cr and a paid-up capital of Rs 1.10 Cr.
The company currently has active open charges totaling ₹26.99 Cr. The company has closed loans amounting to ₹3.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Veeraiah Kavuri, Nadapana Srinivasa, Venkata Edupuganti, and One other member serve as directors at the Company.
- CIN/LLPIN
U24233TG2008PTC059172
- Company No.
059172
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 May 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Kevy's Generics Private Limited offer?
Kevy'S Generics Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Fitness Supplements, Chemical Reagents & Catalysts, Potassium Salts, Fatty Esters, Pharma Ingredients & Raw Materials, API (Active Pharmaceutical Ingredients), Industrial Chemicals & Supplies, Biocides, API Intermediate.
Who are the key members and board of directors at Kevy'S Generics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Veeraiah Kavuri  | Managing Director | 12-Feb-2013 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nadapana Srinivasa | Additional Director | 18-Oct-2013 | Current |
| Venkata Edupuganti | Director | 03-Mar-2014 | Current |
| Srinivasa Reddy | Director | 12-Feb-2013 | Current |
Financial Performance of Kevy'S Generics.
Kevy'S Generics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.33% increase. The company also saw a substantial improvement in profitability, with a 6741.07% increase in profit. The company's net worth moved up by a moderate rise of 5.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kevy'S Generics?
In 2023, Kevy'S Generics had a promoter holding of 88.82% and a public holding of 11.18%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 27 Aug 2022 | ₹1.09 Cr | Open |
Hdfc Bank Limited Creation Date: 29 Sep 2021 | ₹25.90 Cr | Open |
Others Creation Date: 06 Sep 2013 | ₹3.15 Cr | Satisfied |
How Many Employees Work at Kevy'S Generics?
Unlock and access historical data on people associated with Kevy'S Generics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kevy'S Generics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kevy'S Generics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
